NVO
Novo Nordisk A/S
Stock
$37.32−0.08 (−0.21%)Close Oct 2, 2026
Balance sheet
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Cash and short-term investments | DKK 26.5B | DKK 15.7B | DKK 14.4B | DKK 12.7B | DKK 10.7B | DKK 12.2B | DKK 15.4B |
| Inventory | DKK 49.6B | DKK 40.8B | DKK 31.8B | DKK 24.4B | DKK 19.6B | DKK 18.5B | — |
| Current assets | DKK 172.5B | DKK 161.8B | DKK 139.6B | DKK 108.2B | DKK 85.6B | DKK 65.8B | — |
| Goodwill | DKK 19.8B | DKK 20.0B | — | — | — | — | — |
| Intangible assets | DKK 110.2B | DKK 90.8B | DKK 60.4B | DKK 50.9B | DKK 43.2B | DKK 20.7B | — |
| Total assets | DKK 542.9B | DKK 465.6B | DKK 314.5B | DKK 241.3B | DKK 194.5B | DKK 144.9B | — |
| Current liabilities | DKK 215.7B | DKK 217.6B | DKK 169.7B | DKK 120.9B | DKK 99.5B | DKK 70.3B | — |
| Long-term debt | DKK 118.9B | DKK 89.7B | DKK 20.5B | DKK 24.3B | DKK 13.0B | DKK 2.9B | — |
| Total liabilities | DKK 348.9B | DKK 322.1B | DKK 207.9B | DKK 157.8B | DKK 123.8B | DKK 81.6B | — |
| Shareholders' equity | DKK 194.0B | DKK 143.5B | DKK 106.6B | DKK 83.5B | DKK 70.7B | DKK 63.3B | DKK 57.6B |
| Shares outstanding | 4.44B | 4.44B | 4.51B | 2.28B | 2.31B | — | — |
| Current ratio | 0.80 | 0.74 | 0.82 | 0.89 | 0.86 | 0.94 | — |